Ignite Creation Date:
2025-12-24 @ 11:45 AM
Ignite Modification Date:
2026-01-11 @ 2:42 AM
Study NCT ID:
NCT03568461
Status:
COMPLETED
Last Update Posted:
2025-10-07
First Post:
2018-05-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-28
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-24
First Submit QC Date:
None
Study First Post Date:
2018-06-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-06-24
Results First Submit QC Date:
None
Results First Post Date:
2022-07-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-12-21
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-09-18
Last Update Post Date:
2025-10-07
Last Update Post Date Type:
ESTIMATED